Zhejiang East Asia Pharmaceutical Co., Ltd. (SHA:605177)

Market Cap	2.57B +14.9%
Revenue (ttm)	990.47M +2.5%
Net Income	-170.54M
EPS	-1.50
Shares Out	112.55M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,218,800
Open	23.06
Previous Close	22.80
Day's Range	22.26 - 23.71
52-Week Range	13.71 - 24.70
Beta	0.85
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 31, 2026

About SHA:605177

Zhejiang East Asia Pharmaceutical Co., Ltd., together with its subsidiaries, produces and sells pharmaceutical chemicals, tablets, granules, intermediates, and capsules in China and internationally. It offers quinolones synthetic antibacterial agents, antifungal products, gastrointestinal medications, semi-synthetic cephalosporin antibiotics, carbapenem antibiotics, antiviral agents, central nervous system medications, respiratory drugs, antiallergic agents, antineoplastic agents and tumor adjuvant drugs, and other products. The company’s produ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 1,514
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 605177

Financial Performance

In 2025, SHA:605177's revenue was 940.19 million, a decrease of -21.54% compared to the previous year's 1.20 billion. Losses were -82.39 million, -18.15% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 2, 2026

Data Sources Report a data error